Rapacuronium bromide organen teknika

IDrugs

Volumn 2, Issue 7, 1999, Pages 711-717

  Plowman, A N ^a  

^a Department of Anaesthesia Perioperative Medicine and Pain Management ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 DESACETYLRAPACURONIUM; MIVACURIUM; PLACEBO; RAPACURONIUM BROMIDE; SUXAMETHONIUM; UNCLASSIFIED DRUG; VECURONIUM;

BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SYNTHESIS; ENDOTRACHEAL INTUBATION; ERYTHEMA; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STRUCTURE ACTIVITY RELATION; TACHYCARDIA; WHEEZING;

EID: 0032976873     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. 166918 The new relaxants. Mirakhur RK, McCoy EP CURR OPIN ANAESTHESIOL 1994 7 4 365-369
2. 168681 Neuromuscular blocking agents in critically III patients. Van-Miert MM, Hunter JM CURR OPIN ANAESTHESIOL 1994 7 4 375-379
3. 168682 Pharmacodynamics and pharmacokinetics of an Infusion of Org-9487, a new short-acting steroidal neuromuscular blocking agent. Van Den Broek L, Wierda JMKH, Smeulers NJ, Proost JH BRJANAESTH 1994 73 3 331335
4. 168683 Preliminary investigations of the clinical pharmacology of 'three short-acting non-depolarizing neuromuscular blocking agents, Org-9453, Org-9489 and Org-9487. Wierda JM, Beaufort AM, Kleef UW, Smeulers NJ, Agoston S CAN JANAESTH1994 41 3 213-220
5. 168684 Time course of action and endotracheal intubating conditions of Org-9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Wierda JM, Van Den Broek L, Proost JH. Verbaan BW, Hennis PJ ANESTH ANALG 1993 77 3 579-584
6. 170210 Non-depolarizing steroidal muscle relaxant. Prous J, Graul A, Castaner J DRUGS FUTURE 1994 19 10 916-919
7. 193560 Org-9487. DRUGS FUTURE 1995 20 10 1073 ,
8. 196114 Neuromuscular blocking profile of the vecuronium analogue, Org-9487 in the rat isolated hemidiaphragm preparation. Prior C, Tian L, Mallah AI El, Young U Ward JM BR J PHARMACOL 199511673049-3055
9. 221422 Akzo Nobel Pharma human ethicals R&D pipeline. NV Oganon COMPANY COMMUNICATION 1996 October 10
10. 230543 Future developments of non-depolarizing relaxants. Booij LHDJ CURR OPIN ANAESTHESIOL 1996 9 4 331-334
11. 230545 Org-9487 induced neuromuscular block at the adductor pollicis muscle and laryngeal adductor muscles in humans. Debaene B, Billard V, üeutaud T. Meistelman C ANESTHESIOLOGY 1995833AA919
12. 230546 New anaesthetics, analgesics and muscle relaxants for ambulatory surgery. Smith I, White PF CURR OPIN ANAESTHESIOL 199584298-303
13. 230547 The new relaxants. Van Miert MM, Parker CJR CURR ANAESTH CRfT CARE 1995 6 4 235-241
14. 230549 New muscle relaxants. Caldwell JE BAILLIERE'S CUN ANAESTHESIOL 1995 9 1 137-163
15. 23055 Sfructure-pharmacodynarnic-pharrnacokinetic relationships of steroidal neuromuscular blocking agents. Wierda JMKH, Proost JH EUR J ANAESTHESIOL SUPPL199512 11 45-54
16. 230552 New skeletal muscle relaxants. Caldwell JE INT ANESTHESIOL CLIN 1995 33 1 39-60
17. 230554 Research and development of aminosteroid neuromuscular blocking agents: Past and future. Marshall RJ, Muir AW, Sleigh T. Savage DS EUR J ANAESTHESIOL SUPPL 19951211 5-10
18. 230555 Nondepolarizing relaxants: New concepts and new drugs. Kopman A J CUNANESTH1993 5 6 Suppl 39S-45S
19. 230556 Early reversibility of ORG 9467 a new steroidal muscle relaxant Wierda JMKH, Van Den Broek L, Smeulers NJ, Agoston S ANESTHESIOLOGY1992 77 3A A970
20. 230691 Rocuronium and the onset/offset paradox. England AJ ANAESTHESIA 1995 3 3 212-217
21. 241420 Structure: action relationships among some desacetoxy analogs of pancuronium and vecuronium in the anesthetized cat. Bowman WC, Rodger IW, Houston J, Marshall RJ, Mclndewar I ANESTHESIOLOGY 1988 69 27-62
22. 241429 Onset time, peak effect, and cardiovascular effects in adult patients after three different doses of Org-9487. LJchtor JL, Korttila K. Une B, Patil P ANESTHESIOLOGY 1996 85 A305
23. Onset and recovery of Org-9487: A comparison with mivacurium and succinylcholine. Witkowski T, Bartkowski R, Huffnagle S, Lessin J, Marr A. Torjman M ANESTHANALG1997 84 S569
24. 272314 Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates. Proost JH, Roggeveld J, Wierda JMKH, Meijer DKF J PHARMACOL EXP THER1997 282 2 715-726
25. 273336 Information update. DRUGS FUTURE 1997 22 10 11511186
26. 295700 Akzo Nobel NV ANNUAL REPORT 1997 August
27. 302778 Some considerations on the new muscle relaxants. Savarese JJ ANESTHANALG 1998 Suppl 7
28. 302779 Comparison of vecuronium with Org-9487 and their interaction. Schiere S, van Den Broek L, Proost JH, Molenbuur B, Wierda JM CAN J ANAESTH1997 44 11 1138-1143
29. 302780 Org-9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles In humans. Debaene B, Ueutaud T, Billard V, Meistelman C ANESTHESIOLOGY 1997 86 6 1300-5; discussion 7A
30. 302781 Dose-ranging study in younger adult and elderly patients of Org-9487, a new, rapid-onset, short-duration muscle relaxant Kahwaji R, Bevan DR, Bikhazi G, Shanks CA, Fragen RJ, Dyck JB, Angst MS, Matteo R ANESTH ANALG 1997 84 5 10111018
31. 302782 Use of intermediate acting muscle relaxants by infusion: the future. Mirakhur RK, McCourt KC, Kumar N ACTA ANAESTHESIOL BELG1997 48 1 29-34
32. 302783 Effects on laryngeal muscles and intubating conditions with new generation muscle relaxants. Meistelman C ACTA ANAESTHESIOL BELG 1997 48 1 11-14
33. 302784 [New muscle relaxants - A review]. Neue Muskelrelaxantien - eine Standortbestimmung. Schultz A. M, Werba A, Huffman N, Pauser G ACTA CHIR AUSTRIACA 1997 29 6340-343
34. 302785 Neuromuscular relaxants - 1997. Bevan DR CAN J ANAESTH1997 44 11 1135-1137
35. 302787 Intravenous drugs in anaesthesia. Hamilton NM EXP OPIN THER PAT 1997 7 11 1321 -1332
36. 302788 Use of the new neuromuscular blocking drugs In critically ill patients. Scott JM, Hunter JMBRJ INTENSIVE CARE 199665163-164,166-168
37. 302789 Neuromuscular blocking drugs. Savarese JJ CURR OPINANAESTHESIOL 1997 10 4 XXXIII-XXXVI
38. 302790 Neuromuscular blocking drugs: Onset and intubation. Bevan DR J CLINANESTH1997 9 6 SUPPL. 36S-39S
39. 302791 Is suxamethonium now obsolete? Mahajan RP CURR ANAESTH CRIT CARE 1996 7 6 289-294
40. 302792 Org-9487. DRUGS FUTURE 1996 21 101073-1074
41. 302794 Neuromuscular blocking and cardiovascular effects of Org-9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations. Muir AW, Sleigh T. Marshall RJ, Pow E, Anderson KA, Booij LHDJ, Hill DR EUR J ANAESTHESIOL 1998 15 4 467-479
42. 302795 Role of rapid short-acting anesthetics, analgesics and muscle relaxants in ambulatory anesthesia. White PF ACTA ANAESTHESIOL SCAND1997 41 SUPPL. 111 223-226
43. 302798 Neuromuscular effects of Org-9487 compared with 0.2 mg-kg of mivacurium in pédiatrie patients anesthetized with halothane. Kenaan ÇA, Brandon BW, Bikhazi GB, Ginsberg B, Woelfel SK, Ross A, Fonseca JJ ANESTHESIOLOGY 1997 87 3 SupplA1047
44. 302800 Org-9487 vs. succinylcholine in rapid sequence induction for Caesarean section patients: Maternal and neonatal effects. Abboud TK, Bikhazi G, Mroz L, Abouleish E, Lee J, Kenaan C, Larijani G, Goldstein DA ANESTHESIOLOGY 1997 87 3 Suppl A906
45. 302801 Time course of onset and recovery of Org-9487: A comparison with mivacurium and succinylcholine. Fragen RJ, Shanks CA ANESTHESIOLOGY 1997 87 3 Suppl A867
46. 302803 Hemodynamic effects of Org-9487 in adults with coronary artery disease. Fleming N, Safwat A, Wurschmidt R ANESTHESIOLOGY 1997 87 3 Suppl A866
47. 302804 Hemodynamic effects of bolus injection of Org-9487: A comparison with mivacurium and succinylcholine. Witkowski TA, Bartkowski RR, Huffnagle S, Lessin JB, Marr AT, Torjman MC ANESTHESIOLOGY-[997 87 3 Suppl A865
48. 302806 Org-9487 Pharmacodynamics in patients with cirrhosis. Duvaldestin P, Slavov V, Rimaniol J-M ANESTHESIOLOGY 1997 873SupplA864
49. 302807 Onset and duration of vecuronium following either Org-9487 or succinylcholine. Glass PSA, Gan TJ, Jhaveri R, Cooper A ANESTHESIOLOGY 1997 87 3 Suppl A849
50. 302808 Pharmacokinetics and pharmacokinetic-dynamic (PKPD) relationship of Org-9488, the 3-desacetyl metabolite of Org-9487. Schiere S, Proost JH, Wierda JMKH ANESTHESIOLOGY1997 87 3 Suppl A377
51. 302809 Pharmacodynamics of Org-9487: Onset and recovery characteristics of single and three Incremental bolus doses. Mills KG, Scott JM, Parker CJR, Hunter JM BR J ANAESTH 1996 77 5 684P-685P
52. 302810 A dose-ranging study of Org-9487 on endotracheal intubating conditions in infants and children. Motsch J, Meakin G, Meretoja OA, Schoenstedt R, Martin E ANESTHESIOLOGY 1996853AA1084
53. 302811 The EDH of Org-9487 in infants and children. Kaplan RF, Fleteher JE, Hannallah R, Bui DT, Norden J, Slaven S, Darrow E ANESTHESIOLOGY 1996 85 3A A1059
54. 302812 Onset time, peak effect, and cardiovascular effects in adult patients after three different doses of ORG 9407. Uchtor JL, Korttila K, Une B, Patil P ANESTHESIOLOGY 1996 85 3A . A805
55. 302813 'H and "C NMR studies of some steroidal neuromuscular blocking drugs: solution conformations and dynamics. Fielding L MAGNETIC RESONANCE IN CHEM1998 36 6387-397
56. 303191 Onset and recovery of rapacuronium: A comparison with rocuronium. Witkowski T, Bartkowski R, Huffnagle S, Lessin J, Marr A, Torjman M ANESTHESIOLOGY 1998 89 3A A978
57. 315725 Lehman Brothers - HIV/AIDS: do they have the right stuff? ANALYST REPORT 1998 November 4
58. 318791 A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide. Wright PM, Brown R, Lau M, Fisher DM ANESTHESIOLOGY 1999 90 16-23
59. 318793 Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide. Szenohradszky J, Caldwell JE, Wright PM, Brown R, Lau M, Luks AM, Fisher DM ANESTHESIOLOGY1999 90 24-35
60. 319211 Rapacuronium set for registration. Organon (Australia) Ply Ltd COMPANY COMMUNICATION 1999 March 23 A spokesman from Organon in Australia stated that a meeting was held in Europe on 8 February 1999 to brief company employees on the registration and release of Raplon (rapacuronium bromide).
61. 320706 Organon Teknika obtains exclusive rights of analgesic compound. Akzo Nobel NV PRESS RELEASE 1999 April 8
62. 326681 Factors affecting the pharmacokinetic characteristics of rapacuronium. Fisher DM, Kahwaji R, Bevan D, Bikhazi G, Fragen RJ, Angst MS, Omstein E, Matteo RS ANESTHESIOLOGY (1999) 904993-1000
63. 327554 Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue Obtained during cardiac surgery. Sato K, Windisch K, Matko I, Vizi VS BR J ANAESTH1999 82 6 904-909
64. 327555 Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org-9487 (rapacuronium) or rocuronium following an initial dose of Org9487. McCourt KC, Mirakhur RK, Lowry DW, Carroll MT, Sparr HJ BR J ANAESTH 1999 82 5 755-756
65. 327556 Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org-9487) and its 3desacetyl metabolite (Org-9488). Schiere S, Proost JH, Schuringa M, Wierda JM ANESTHANALG1999 88 3 640-647
66. 327557 Comparison of intubating conditions after rapacuronium (Org-9487) and succinylcholine following rapid sequence induction in adult patients. Sparr HJ, Mellinghoff H, Blobner MetalBRJ ANAESTH 1999 82 4 537-541
67. 327560 Steroidal neuromuscular blocking agents. Wierda JM INT CONOR SER EXCERPTA MED 1998 1164 43-49
68. Rapacuronium (Org-9487): Do we have a replacement for succinylcholine? Goulden MR, Hunter JM BR J ANAESTH 1999824489-492
69. 327561 The pulmonary first-pass uptake of five nondepolarizing muscle relaxants in the pig. Beaufort TM, Proost JH, Houwertjes MC, Roggeveid J, Wierda JM ANESTHES1OLOGY1999 90 2 477-483
70. 327562 Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Atherton DPL, Hunter JM CLIN PHARMACOKIN 1999363169-189
71. 327563 Cardiovascular effects of Org-9487 under isoflurane anaesthesia in man. Osmer C, Wulf K, Vögele K, Zickmann B, Hempelmann G EUR JANAESTHESIOL1998 15 5 585-589